Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets
NHS hospitals in England used £30,628,861 of indicative cost of Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is down 1.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Chelsea & Westminster Hospital Nhs Ft | £3,435,889 |
| Guy's & St Thomas' Nhs Foundation Trust | £2,219,862 |
| Manchester University Nhs Ft | £1,663,737 |
| Western Sussex Hospitals Nhs Found Trust | £1,601,236 |
| St George's Univ Hosps Foundation Nhst | £1,475,924 |
| Imperial College Healthcare Nhs Trust | £1,466,770 |
| Royal Free London Nhs Foundation Trust | £1,277,948 |
| University College London Foundation Tr | £1,095,529 |
| Barts Health Nhs Trust | £1,013,451 |
| King's College Hpl Nhs Foundation Trust | £736,717 |
The primary-care picture
Emtricitabine is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Emtricitabine medicine page.